Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune

Current Science

Volumn 105, Issue 4, 2013, Pages 486-491

  Sinha, Archana ^a,d   Kumar, Rajan ^a,d   Pawar, Bhagawan ^b,c   Bhide, Anuradha ^a,e   Javadekar, Shubhada Suresh ^a,f   Vijayakumar, Maleppillil Vavachan ^g   Pandey, Vimal ^g   Bhat, Manoj Kumar ^g  

^a Byramjee Jeejeebhoy Medical College Clinical Trials Unit   (India)

^b State Bureau of Health Information and Vital Statistics   (India)

^c Office of the Joint Director TB and Leprosy   (India)

^d HOWARD UNIVERSITY HOSPITAL   (United States)

^e GRANT MEDICAL COLLEGE   (India)

^f Maharashtra Institute of Medical Education and Research (MIMER Medical College)   (India)

^g NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Cancer; Death certificate; Diabetes; Indian population; Mortality

Indexed keywords

EID: 84883747593     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rao, D. N. and Ganesh, B., Estimate of cancer incidence in India in 1991. Indian J. Cancer, 1998, 35, 10-18.
2. Takiar, R., Nadayil, D. and Nandakumar, A., Projections of num-ber of cancer cases in India (2010-2020) by cancer groups. Asian Pac. J. Cancer Prev., 2010, 11, 1045-1049.
3. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27, 1047-1053.
4. La Vecchia, C., Negri, E., Franceschi, S., D'Avanzo, B. and Boyle, P., A case control study of diabetes mellitus and cancer risk. Br. J. Cancer, 1994, 70, 950-953.
5. Jee, S. H., Ohrr, H., Sull, J. W., Yun, J. E., Ji, M. and Samet, J. M., Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 2005, 293, 194-202.
6. Lo, S. F. et al., Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int. J. Cancer, 2013, 2013, 132, 182-188.
7. Czyzyk, A. and Szczepanik, Z., Diabetes mellitus and cancer. Eur. J. Intern. Med., 2000, 11, 245-252.
8. Verlato, G., Zoppin, I. G., Bonora, E. and Muggeo, M., Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care, 2003, 26, 1047-1051.
9. Coughlin, S. S. et al., Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am. J. Epidemiol., 2004, 159, 1160-1167.
10. Larsson, S. C., Orsini, N. and Wolk, A., Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J. Natl. Cancer Inst., 2005, 97, 1679-1686.
11. Simon, D. and Balkau, B., Diabetes mellitus, hyperglycaemia and cancer. Diabetes Metab., 2010, 36, 182-191.
12. Kim, Y. I., Diet, lifestyle and colorectal cancer: Is hyperinsuline-mia the missing link? Nutr. Rev., 1998, 56, 275-279.
13. Spence, M., McKinley, M. C. and Hunter, S. J., Session 4: CVD, diabetes and cancer: Diet, insulin resistance and diabetes: the right (pro)portions. Proc. Nutr. Soc., 2010, 69, 61-69.
14. Balkau, B., Eschwege, E., Ducimetiere, P., Richard, J. L. and Warnet, J. M., The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris prospective study after 15 years of follow-up. J. Clin. Epidemiol., 1991, 44, 465-474.
15. Ortiz, A. P., Romero, C., Disdier, O., Santana, E., Torres, M., Tor-res, E. A. and Pérez, C. M., Diabetes is associated with chronic liver disease and liver cancer in the adult population of Puerto Rico. P.R. Health Sci. J., 2011, 30, 132-134.
16. Tierney, E. F. et al., Population-based estimates of mortality asso-ciated with diabetes: use of a death certificate check box in North Dakota. Am. J. Public Health, 2001, 91, 84-92.
17. Vigneri, P., Frasca, F., Sciacca, L., Pandini, G. and Vigneri, R., Diabetes and cancer. Endocr. Relat. Cancer, 2009, 16, 1103-1123.
18. Suh, S.and Kim, K. W., Diabetesand cancer: is diabetes causally related to cancer? Diabetes Metab. J., 2011, 35, 193-198.
19. Carstensen, B., Witte, D. R.and Friis, S., Cancer occurrence in Danish diabetic patients: durationand insulin effects. Diabetolo-gia, 2012, 55, 948-958.
20. Ferrara, A., Barrett-Connor, E., Wingard, D. L.and Edelstein, S. L., Sex differencesand insulin levels in older adultsand the effect of body size, estrogen replacement therapy,and glucose tolerance status. The Rancho Bernardo Study, 1984-1987. Diabetes Care, 1995, 18, 220-225.
21. Li, D., Diabetesand pancreatic cancer. Mol. Carcinog., 2012, 51, 64-74.
22. Schwarts, S. S., Zeidler, A., Moossa, A. R., Kuku, S. F.and Rubenstein, A. H., A prospective study of glucose tolerance, insu-lin, C-peptide,and glucagon responses in patients with pancreatic carcinoma. Dig. Dis., 1978, 23, 1107-1114.
23. Basso, D. et al., Putative pancreatic cancer-associated diabeto-genic factor: 2030 MW peptide. Pancreas, 2002, 24, 8-14.
24. Liu, J., Knezetic, J. A., Strömmer, L., Permert, J., Larsson, J.and Adrian, T. E., The intracellular mechanism of insulin resistance in pancreatic cancer patients. J. Clin. Endocrinol. Metab., 2000, 85, 1232-1238.
25. Liu, J., Kazakoff, K., Pour, P. M.and Adrian, T. E., The intracel-lular mechanism of insulin resistance in the hamster pancreatic ductal adenocarcinoma model. Pancreas, 1998, 17, 359-366.
26. Basso, D., Brigato, L., Veronesi, A., Panozzo, M. P., Amadori, A.and Plebani, M., The pancreatic cancer cell line MIA PaCa2 pro-duces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res., 1995, 15, 2585-2588.
27. Wolf, I., Sadetzki, S., Catanae, R., Karasik, A.and Kaufman, B., Diabetes mellitusand breast cancer. Lancet Oncol., 2005, 6, 103-111.
28. Julien, S. G. et al., Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumourigenesisand protects from lung metastasis. Nat. Genet., 2007, 39, 338-346.
29. McEwen, L. N., Pomeroy, N. E., Onymere, K.and Herman, W. H., Are primary care physicians more likely to record diabetes on death certificates? Diabetes Care, 2008, 31, 508-510.
30. Stattin, P. et al., Prospective study of hyperglycemiaand cancer risk. Diabetes Care, 2007, 30, 561-567.
31. Dankner, R. et al., Diabetes, glucose control, glucose lowering medications,and cancer risk: A 10-year population-based histori-cal cohort. BMC Cancer, 2012, 12, 364.